List of Excipients in API dutasteride and tamsulosin hydrochloride
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing dutasteride and tamsulosin hydrochloride
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| GlaxoSmithKline LLC | JALYN | dutasteride and tamsulosin hydrochloride | 0173-0809 | BUTYLATED HYDROXYTOLUENE | |
| GlaxoSmithKline LLC | JALYN | dutasteride and tamsulosin hydrochloride | 0173-0809 | CARRAGEENAN | |
| GlaxoSmithKline LLC | JALYN | dutasteride and tamsulosin hydrochloride | 0173-0809 | CELLULOSE, MICROCRYSTALLINE | |
| GlaxoSmithKline LLC | JALYN | dutasteride and tamsulosin hydrochloride | 0173-0809 | FD&C YELLOW NO. 6 | |
| GlaxoSmithKline LLC | JALYN | dutasteride and tamsulosin hydrochloride | 0173-0809 | FERRIC OXIDE RED | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing dutasteride and tamsulosin hydrochloride
Detailed excipient profiles for dutasteride and tamsulosin hydrochloride
Excipient focus: ALCOHOL
dutasteride and tamsulosin hydrochloride drug variants containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals USA Inc | dutasteride and tamsulosin hydrochloride | 68382-640 |
| Zydus Lifesciences Limited | dutasteride and tamsulosin hydrochloride | 70771-1356 |
| >Company | >Ingredient | >NDC |
dutasteride and tamsulosin hydrochloride drug variants not containing ALCOHOL
Excipient focus: AMMONIA
dutasteride and tamsulosin hydrochloride drug variants containing AMMONIA
dutasteride and tamsulosin hydrochloride drug variants not containing AMMONIA
Excipient focus: BUTYL ALCOHOL
dutasteride and tamsulosin hydrochloride drug variants containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals USA Inc | dutasteride and tamsulosin hydrochloride | 68382-640 |
| Zydus Lifesciences Limited | dutasteride and tamsulosin hydrochloride | 70771-1356 |
| >Company | >Ingredient | >NDC |
dutasteride and tamsulosin hydrochloride drug variants not containing BUTYL ALCOHOL
Excipient focus: BUTYLATED HYDROXYTOLUENE
dutasteride and tamsulosin hydrochloride drug variants containing BUTYLATED HYDROXYTOLUENE
dutasteride and tamsulosin hydrochloride drug variants not containing BUTYLATED HYDROXYTOLUENE
| Company | Ingredient | NDC |
|---|---|---|
| Waylis Therapeutics | dutasteride and tamsulosin hydrochloride | 80725-809 |
| >Company | >Ingredient | >NDC |
Excipient focus: CALCIUM STEARATE
dutasteride and tamsulosin hydrochloride drug variants containing CALCIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | dutasteride and tamsulosin hydrochloride | 59651-063 |
| >Company | >Ingredient | >NDC |
dutasteride and tamsulosin hydrochloride drug variants not containing CALCIUM STEARATE
Excipient focus: CAPRYLIC/CAPRIC MONO/DI-GLYCERIDES
dutasteride and tamsulosin hydrochloride drug variants containing CAPRYLIC/CAPRIC MONO/DI-GLYCERIDES
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals USA Inc | dutasteride and tamsulosin hydrochloride | 68382-640 |
| Zydus Lifesciences Limited | dutasteride and tamsulosin hydrochloride | 70771-1356 |
| >Company | >Ingredient | >NDC |
dutasteride and tamsulosin hydrochloride drug variants not containing CAPRYLIC/CAPRIC MONO/DI-GLYCERIDES
Excipient focus: CAPRYLIC/CAPRIC MONO/DIGLYCERIDES
dutasteride and tamsulosin hydrochloride drug variants containing CAPRYLIC/CAPRIC MONO/DIGLYCERIDES
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | dutasteride and tamsulosin hydrochloride | 54868-6328 |
| >Company | >Ingredient | >NDC |
dutasteride and tamsulosin hydrochloride drug variants not containing CAPRYLIC/CAPRIC MONO/DIGLYCERIDES
Excipient focus: CARRAGEENAN
dutasteride and tamsulosin hydrochloride drug variants containing CARRAGEENAN
dutasteride and tamsulosin hydrochloride drug variants not containing CARRAGEENAN
| Company | Ingredient | NDC |
|---|---|---|
| Waylis Therapeutics | dutasteride and tamsulosin hydrochloride | 80725-809 |
| Par Pharmaceutical Inc | dutasteride and tamsulosin hydrochloride capsules | 10370-280 |
| AvKARE | dutasteride and tamsulosin hydrochloride capsules | 42291-031 |
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
dutasteride and tamsulosin hydrochloride drug variants containing CELLULOSE, MICROCRYSTALLINE
dutasteride and tamsulosin hydrochloride drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Par Pharmaceutical Inc | dutasteride and tamsulosin hydrochloride capsules | 10370-280 |
| AvKARE | dutasteride and tamsulosin hydrochloride capsules | 42291-031 |
| >Company | >Ingredient | >NDC |
Excipient focus: D&C YELLOW NO. 10
dutasteride and tamsulosin hydrochloride drug variants containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| Par Pharmaceutical Inc | dutasteride and tamsulosin hydrochloride capsules | 10370-280 |
| AvKARE | dutasteride and tamsulosin hydrochloride capsules | 42291-031 |
| >Company | >Ingredient | >NDC |
dutasteride and tamsulosin hydrochloride drug variants not containing D&C YELLOW NO. 10
Excipient focus: ETHYLCELLULOSE
dutasteride and tamsulosin hydrochloride drug variants containing ETHYLCELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Par Pharmaceutical Inc | dutasteride and tamsulosin hydrochloride capsules | 10370-280 |
| AvKARE | dutasteride and tamsulosin hydrochloride capsules | 42291-031 |
| >Company | >Ingredient | >NDC |
dutasteride and tamsulosin hydrochloride drug variants not containing ETHYLCELLULOSE
Excipient focus: FD&C BLUE NO. 1
dutasteride and tamsulosin hydrochloride drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Par Pharmaceutical Inc | dutasteride and tamsulosin hydrochloride capsules | 10370-280 |
| AvKARE | dutasteride and tamsulosin hydrochloride capsules | 42291-031 |
| >Company | >Ingredient | >NDC |
dutasteride and tamsulosin hydrochloride drug variants not containing FD&C BLUE NO. 1
Excipient focus: FD&C BLUE NO. 2
dutasteride and tamsulosin hydrochloride drug variants containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Par Pharmaceutical Inc | dutasteride and tamsulosin hydrochloride capsules | 10370-280 |
| AvKARE | dutasteride and tamsulosin hydrochloride capsules | 42291-031 |
| >Company | >Ingredient | >NDC |
dutasteride and tamsulosin hydrochloride drug variants not containing FD&C BLUE NO. 2
Excipient focus: FD&C RED NO. 40
dutasteride and tamsulosin hydrochloride drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Par Pharmaceutical Inc | dutasteride and tamsulosin hydrochloride capsules | 10370-280 |
| AvKARE | dutasteride and tamsulosin hydrochloride capsules | 42291-031 |
| >Company | >Ingredient | >NDC |
dutasteride and tamsulosin hydrochloride drug variants not containing FD&C RED NO. 40
Excipient focus: FD&C YELLOW NO. 6
dutasteride and tamsulosin hydrochloride drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| GlaxoSmithKline LLC | dutasteride and tamsulosin hydrochloride | 0173-0809 |
| Physicians Total Care Inc | dutasteride and tamsulosin hydrochloride | 54868-6328 |
| Aurobindo Pharma Limited | dutasteride and tamsulosin hydrochloride | 59651-063 |
| >Company | >Ingredient | >NDC |
dutasteride and tamsulosin hydrochloride drug variants not containing FD&C YELLOW NO. 6
Excipient focus: FERRIC OXIDE RED
dutasteride and tamsulosin hydrochloride drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| GlaxoSmithKline LLC | dutasteride and tamsulosin hydrochloride | 0173-0809 |
| Physicians Total Care Inc | dutasteride and tamsulosin hydrochloride | 54868-6328 |
| Aurobindo Pharma Limited | dutasteride and tamsulosin hydrochloride | 59651-063 |
| >Company | >Ingredient | >NDC |
dutasteride and tamsulosin hydrochloride drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
dutasteride and tamsulosin hydrochloride drug variants containing FERRIC OXIDE YELLOW
dutasteride and tamsulosin hydrochloride drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Waylis Therapeutics | dutasteride and tamsulosin hydrochloride | 80725-809 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
dutasteride and tamsulosin hydrochloride drug variants containing FERROSOFERRIC OXIDE
dutasteride and tamsulosin hydrochloride drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| GlaxoSmithKline LLC | dutasteride and tamsulosin hydrochloride | 0173-0809 |
| Physicians Total Care Inc | dutasteride and tamsulosin hydrochloride | 54868-6328 |
| Waylis Therapeutics | dutasteride and tamsulosin hydrochloride | 80725-809 |
| >Company | >Ingredient | >NDC |
Excipient focus: GELATIN
dutasteride and tamsulosin hydrochloride drug variants containing GELATIN
dutasteride and tamsulosin hydrochloride drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| Waylis Therapeutics | dutasteride and tamsulosin hydrochloride | 80725-809 |
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERIN
dutasteride and tamsulosin hydrochloride drug variants containing GLYCERIN
dutasteride and tamsulosin hydrochloride drug variants not containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| Waylis Therapeutics | dutasteride and tamsulosin hydrochloride | 80725-809 |
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERYL CAPRYLOCAPRATE
dutasteride and tamsulosin hydrochloride drug variants containing GLYCERYL CAPRYLOCAPRATE
| Company | Ingredient | NDC |
|---|---|---|
| GlaxoSmithKline LLC | dutasteride and tamsulosin hydrochloride | 0173-0809 |
| >Company | >Ingredient | >NDC |
dutasteride and tamsulosin hydrochloride drug variants not containing GLYCERYL CAPRYLOCAPRATE
Excipient focus: GLYCERYL MONO- AND DICAPRYLOCAPRATE
dutasteride and tamsulosin hydrochloride drug variants containing GLYCERYL MONO- AND DICAPRYLOCAPRATE
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | dutasteride and tamsulosin hydrochloride | 59651-063 |
| >Company | >Ingredient | >NDC |
dutasteride and tamsulosin hydrochloride drug variants not containing GLYCERYL MONO- AND DICAPRYLOCAPRATE
Excipient focus: HYPROMELLOSE
dutasteride and tamsulosin hydrochloride drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| GlaxoSmithKline LLC | dutasteride and tamsulosin hydrochloride | 0173-0809 |
| Aurobindo Pharma Limited | dutasteride and tamsulosin hydrochloride | 59651-063 |
| >Company | >Ingredient | >NDC |
dutasteride and tamsulosin hydrochloride drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSES
dutasteride and tamsulosin hydrochloride drug variants containing HYPROMELLOSES
dutasteride and tamsulosin hydrochloride drug variants not containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| GlaxoSmithKline LLC | dutasteride and tamsulosin hydrochloride | 0173-0809 |
| Aurobindo Pharma Limited | dutasteride and tamsulosin hydrochloride | 59651-063 |
| Waylis Therapeutics | dutasteride and tamsulosin hydrochloride | 80725-809 |
| >Company | >Ingredient | >NDC |
Excipient focus: ISOPROPYL ALCOHOL
dutasteride and tamsulosin hydrochloride drug variants containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals USA Inc | dutasteride and tamsulosin hydrochloride | 68382-640 |
| Zydus Lifesciences Limited | dutasteride and tamsulosin hydrochloride | 70771-1356 |
| >Company | >Ingredient | >NDC |
dutasteride and tamsulosin hydrochloride drug variants not containing ISOPROPYL ALCOHOL
Excipient focus: LECITHIN, SOYBEAN
dutasteride and tamsulosin hydrochloride drug variants containing LECITHIN, SOYBEAN
| Company | Ingredient | NDC |
|---|---|---|
| Par Pharmaceutical Inc | dutasteride and tamsulosin hydrochloride capsules | 10370-280 |
| AvKARE | dutasteride and tamsulosin hydrochloride capsules | 42291-031 |
| >Company | >Ingredient | >NDC |
dutasteride and tamsulosin hydrochloride drug variants not containing LECITHIN, SOYBEAN
Excipient focus: MEDIUM-CHAIN TRIGLYCERIDES
dutasteride and tamsulosin hydrochloride drug variants containing MEDIUM-CHAIN TRIGLYCERIDES
| Company | Ingredient | NDC |
|---|---|---|
| Par Pharmaceutical Inc | dutasteride and tamsulosin hydrochloride capsules | 10370-280 |
| AvKARE | dutasteride and tamsulosin hydrochloride capsules | 42291-031 |
| >Company | >Ingredient | >NDC |
dutasteride and tamsulosin hydrochloride drug variants not containing MEDIUM-CHAIN TRIGLYCERIDES
Excipient focus: METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER
dutasteride and tamsulosin hydrochloride drug variants containing METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER
dutasteride and tamsulosin hydrochloride drug variants not containing METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER
Excipient focus: METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
dutasteride and tamsulosin hydrochloride drug variants containing METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
dutasteride and tamsulosin hydrochloride drug variants not containing METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
Excipient focus: METHYLPARABEN
dutasteride and tamsulosin hydrochloride drug variants containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals USA Inc | dutasteride and tamsulosin hydrochloride | 68382-640 |
| Zydus Lifesciences Limited | dutasteride and tamsulosin hydrochloride | 70771-1356 |
| >Company | >Ingredient | >NDC |
dutasteride and tamsulosin hydrochloride drug variants not containing METHYLPARABEN
Excipient focus: POLYETHYLENE GLYCOL
dutasteride and tamsulosin hydrochloride drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Par Pharmaceutical Inc | dutasteride and tamsulosin hydrochloride capsules | 10370-280 |
| AvKARE | dutasteride and tamsulosin hydrochloride capsules | 42291-031 |
| >Company | >Ingredient | >NDC |
dutasteride and tamsulosin hydrochloride drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYVINYL ACETATE PHTHALATE
dutasteride and tamsulosin hydrochloride drug variants containing POLYVINYL ACETATE PHTHALATE
| Company | Ingredient | NDC |
|---|---|---|
| Par Pharmaceutical Inc | dutasteride and tamsulosin hydrochloride capsules | 10370-280 |
| AvKARE | dutasteride and tamsulosin hydrochloride capsules | 42291-031 |
| >Company | >Ingredient | >NDC |
dutasteride and tamsulosin hydrochloride drug variants not containing POLYVINYL ACETATE PHTHALATE
Excipient focus: POTASSIUM CHLORIDE
dutasteride and tamsulosin hydrochloride drug variants containing POTASSIUM CHLORIDE
dutasteride and tamsulosin hydrochloride drug variants not containing POTASSIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Waylis Therapeutics | dutasteride and tamsulosin hydrochloride | 80725-809 |
| Par Pharmaceutical Inc | dutasteride and tamsulosin hydrochloride capsules | 10370-280 |
| AvKARE | dutasteride and tamsulosin hydrochloride capsules | 42291-031 |
| >Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM HYDROXIDE
dutasteride and tamsulosin hydrochloride drug variants containing POTASSIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | dutasteride and tamsulosin hydrochloride | 59651-063 |
| Zydus Pharmaceuticals USA Inc | dutasteride and tamsulosin hydrochloride | 68382-640 |
| Zydus Lifesciences Limited | dutasteride and tamsulosin hydrochloride | 70771-1356 |
| >Company | >Ingredient | >NDC |
dutasteride and tamsulosin hydrochloride drug variants not containing POTASSIUM HYDROXIDE
Excipient focus: PROPYLENE GLYCOL
dutasteride and tamsulosin hydrochloride drug variants containing PROPYLENE GLYCOL
dutasteride and tamsulosin hydrochloride drug variants not containing PROPYLENE GLYCOL
Excipient focus: PROPYLPARABEN
dutasteride and tamsulosin hydrochloride drug variants containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals USA Inc | dutasteride and tamsulosin hydrochloride | 68382-640 |
| Zydus Lifesciences Limited | dutasteride and tamsulosin hydrochloride | 70771-1356 |
| >Company | >Ingredient | >NDC |
dutasteride and tamsulosin hydrochloride drug variants not containing PROPYLPARABEN
Excipient focus: SHELLAC
dutasteride and tamsulosin hydrochloride drug variants containing SHELLAC
dutasteride and tamsulosin hydrochloride drug variants not containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| GlaxoSmithKline LLC | dutasteride and tamsulosin hydrochloride | 0173-0809 |
| Physicians Total Care Inc | dutasteride and tamsulosin hydrochloride | 54868-6328 |
| Waylis Therapeutics | dutasteride and tamsulosin hydrochloride | 80725-809 |
| >Company | >Ingredient | >NDC |
Excipient focus: SUCROSE
dutasteride and tamsulosin hydrochloride drug variants containing SUCROSE
| Company | Ingredient | NDC |
|---|---|---|
| Par Pharmaceutical Inc | dutasteride and tamsulosin hydrochloride capsules | 10370-280 |
| AvKARE | dutasteride and tamsulosin hydrochloride capsules | 42291-031 |
| >Company | >Ingredient | >NDC |
dutasteride and tamsulosin hydrochloride drug variants not containing SUCROSE
Excipient focus: TALC
dutasteride and tamsulosin hydrochloride drug variants containing TALC
dutasteride and tamsulosin hydrochloride drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
dutasteride and tamsulosin hydrochloride drug variants containing TITANIUM DIOXIDE
dutasteride and tamsulosin hydrochloride drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Waylis Therapeutics | dutasteride and tamsulosin hydrochloride | 80725-809 |
| >Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
dutasteride and tamsulosin hydrochloride drug variants containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | dutasteride and tamsulosin hydrochloride | 59651-063 |
| Zydus Pharmaceuticals USA Inc | dutasteride and tamsulosin hydrochloride | 68382-640 |
| Zydus Lifesciences Limited | dutasteride and tamsulosin hydrochloride | 70771-1356 |
| >Company | >Ingredient | >NDC |
dutasteride and tamsulosin hydrochloride drug variants not containing TRIACETIN
Excipient focus: TRIETHYL CITRATE
dutasteride and tamsulosin hydrochloride drug variants containing TRIETHYL CITRATE
dutasteride and tamsulosin hydrochloride drug variants not containing TRIETHYL CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | dutasteride and tamsulosin hydrochloride | 59651-063 |
| Zydus Pharmaceuticals USA Inc | dutasteride and tamsulosin hydrochloride | 68382-640 |
| Zydus Lifesciences Limited | dutasteride and tamsulosin hydrochloride | 70771-1356 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
